bit.bio was featured on Massive Science.
Product Manager Dr Tonya Frolov explains why animals are not always the ideal stand-in when studying potential treatments for diseases that represent the biggest threats to human health which includes Alzheimer's. The high failure rate of potential drugs have something in common: they were all tested initially in mouse models, but the big problem is: mice don't get Alzheimer's.
From Animal Models to A Human Alternative
The piece goes on to cover how bit.bio is dedicated to succeed at the production of pure, tissue-specific cell populations for biological research and pharmaceutical development.
Read the full article on Massive Science.